how many americans take glp-1 drugs Nearly 12% of have used drugs—such as Ozempic—for weight loss. 14% say they're interested in them. New findings from the largest and most recent survey on Americans' use of a Map Shows States Where Weight
Description
There is also further ongoing research to understand the mechanisms of GIP agonism versus antagonism to decide on the optimal weight loss and antihyperglycemic approach
Figure 3 Effects on Atherosclerosis Atherosclerosis (AS) is a fibrolipopathic formation on the arterial wall and a main cause of death worldwide
doi: 10.1038/nchembio.1665
Hospitals are involved in many clinical trials assessing GLP-1 agonists
10.1097/GME.0000000000000640 20
Journal of Diabetes 10353356
